SRTS Sensus Healthcare, Inc.
Healthcare$3.20+0.31%ClosedMarket Cap: $52.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.15
P/S
2.33
EV/EBITDA
-4.04
DCF Value
$1.09
FCF Yield
-1.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
37.7%
Operating Margin
-53.3%
Net Margin
-34.5%
ROE
-15.8%
ROA
-15.1%
ROIC
-17.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.4M | 29.2% | $-4.4M | $-2.6M | $— | — |
| Q4 null | $4.9M | 38.4% | $-3.1M | $-3.2M | $— | — |
| FY null | $27.5M | 43.2% | $-10.3M | $-7.7M | $— | — |
| Q3 null | $6.9M | 39.4% | $-2.6M | $-943.0K | $— | — |
| Q2 null | $7.3M | 39.7% | $-1.9M | $-1.0M | $— | — |
| Q1 null | $8.3M | 52.2% | $-2.6M | $-2.6M | $— | — |
| Q4 null | $13.1M | 54.4% | $1.7M | $1.5M | $— | — |
| FY null | $41.8M | 58.4% | $8.1M | $6.6M | $— | — |
| Q3 null | $8.8M | 59.3% | $1.5M | $1.2M | $— | — |
| Q2 null | $9.2M | 58.7% | $2.0M | $1.6M | $— | — |
| Q1 null | $10.7M | 62.5% | $2.9M | $2.3M | $— | — |
| Q4 2023 | $12.6M | 62.3% | $5.6M | $4.2M | $0.26 | — |